|
1
|
Halliday J, Helmy K, Pattwell SS, Pitter
KL, LaPlant Q, Ozawa T and Holland EC: In vivo radiation response
of proneural glioma characterized by protective p53 transcriptional
program and proneural-mesenchymal shift. Proc Natl Acad Sci USA.
111:pp. 5248–5253. 2014; View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Oishi N, Yamashita T and Kaneko S:
Molecular biology of liver cancer stem cells. Liver Cancer.
3:71–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ryerson AB, Eheman CR, Altekruse SF, Ward
JW, Jemal A, Sherman RL, Henley SJ, Holtzman D, Lake A, Noone AM,
et al: Annual Report to the Nation on the Status of Cancer,
1975–2012, featuring the increasing incidence of liver cancer.
Cancer. 122:1312–1337. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Y, Liu S, Wang X, Zhang Z, Jing X,
Zhang P and Xie Z: Prevention of local liver cancer recurrence
after surgery using multilayered cisplatin-loaded polylactide
electrospun nanofibers. Chin J Polym Sci. 8:1111–1118. 2014.
View Article : Google Scholar
|
|
6
|
Bruix J, Han KH, Gores G, Llovet JM and
Mazzaferro V: Liver cancer: Approaching a personalized care. J
Hepatol. 62 Suppl 1:S144–S156. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fiore F, Del Prete M, Franco R, Marotta V,
Ramundo V, Marciello F, Di Sarno A, Carratù AC, de Luca di Roseto
C, Colao A, et al: Transarterial embolization (TAE) is equally
effective and slightly safer than transarterial chemoembolization
(TACE) to manage liver metastases in neuroendocrine tumors.
Endocrine. 47:177–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee DS and Seong J: Radiotherapeutic
options for hepatocellular carcinoma with portal vein tumor
thrombosis. Liver Cancer. 3:18–30. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Im JH, Yoon SM, Park HC, Kim JH, Yu JI,
Kim TH, Kim JW, Nam TK, Kim K, Jang HS, et al: Radiotherapeutic
strategies for hepatocellular carcinoma with portal vein tumour
thrombosis in a hepatitis B endemic area. Liver Int. 37:90–100.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Phillips WT, Bao A, Brenner AJ and Goins
BA: Image-guided interventional therapy for cancer with
radiotherapeutic nanoparticles. Adv Drug Deliv Rev. 76:39–59. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Freed-Pastor W and Prives C: Targeting
mutant p53 through the mevalonate pathway. Nat Cell Biol.
18:1122–1124. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Muller PA and Vousden KH: p53 mutations in
cancer. Nat Cell Biol. 15:2–8. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Muller PA and Vousden KH: Mutant p53 in
cancer: New functions and therapeutic opportunities. Cancer Cell.
25:304–317. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lencioni R and Llovet JM: Modified RECIST
(mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis.
1:52–60. 2010. View Article : Google Scholar
|
|
15
|
Xia J, Ren Z, Ye S, Sharma D, Lin Z, Gan
Y, Chen Y, Ge N, Ma Z, Wu Z, et al: Study of severe and rare
complications of transarterial chemoembolization (TACE) for liver
cancer. Eur J Radiol. 59:407–412. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jihye C and Jinsil S: Application of
radiotherapeutic strategies in the BCLC-defined stages of
hepatocellular carcinoma. Liver Cancer. 1:216–225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Herfarth KK, Debus J, Lohr F, Bahner ML,
Rhein B, Fritz P, Höss A, Schlegel W and Wannenmacher MF:
Stereotactic single-dose radiation therapy of liver tumors: Results
of a phase I/II trial. J Clin Oncol. 19:164–170. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Salem R, Thurston KG, Carr BI, Goin JE and
Geschwind JF: Yttrium-90 microspheres: Radiation therapy for
unresectable liver cancer. J Vasc Interv Radiol. 13:S223–S229.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Matsuura M, Nakajima N, Arai K and Ito K:
The usefulness of radiation therapy for hepatocellular carcinoma.
Hepatogastroenterology. 45:791–796. 1998.PubMed/NCBI
|
|
20
|
Seong J, Keum KC, Han KH, Lee DY, Lee JT,
Chon CY, Moon YM, Suh CO and Kim GE: Combined transcatheter
arterial chemoembolization and local radiotherapy of unresectable
hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 43:393–397.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jung WS and Shin RM: The effect of patient
position on dose in radiation therapy of liver cancer. J Korean Soc
Radiotherapeutic Technol. 1:1–9. 2014.
|
|
22
|
Roake CM and Artandi SE: Control of
cellular aging, tissue function, and cancer by p53 downstream of
telomeres. Cold Spring Harb Perspect Med. 7:260882017. View Article : Google Scholar
|
|
23
|
Smet FD, Rubio M and Hompes S: Nuclear
inclusion bodies of mutant and wild-type p53 in cancer: A hallmark
of p53 inactivation and proteostasis remodeling by p53 aggregation.
J Pathol. 2:875–882. 2016.
|
|
24
|
Rahman M, Lovat F, Romano G, Calore F,
Acunzo M, Bell EH and Nana-Sinkam P: miR-15b/16-2 regulates factors
that promote p53 phosphorylation and augments the DNA damage
response following radiation in the lung. J Biol Chem.
289:26406–26416. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rubner Y, Muth C, Strnad A, Derer A,
Sieber R, Buslei R, Frey B, Fietkau R and Gaipl US: Fractionated
radiotherapy is the main stimulus for the induction of cell death
and of Hsp70 release of p53 mutated glioblastoma cell lines. Radiat
Oncol. 9:892014. View Article : Google Scholar : PubMed/NCBI
|
